Igor Kos

4PUBLICATIONS
11CO-AUTHORS
Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Bioprocessing, bioproduction and bioproducts
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 21, 2026
Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.

|Apr 18, 2025
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.

Jan H Frenking, Christine Riedhammer, Raphael Teipel

|Mar 31, 2021
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.

Igor Kos, Benedikt Balensiefer, Vadim Lesan

|Sep 20, 2018
Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market.

Morton Aaron Scheinberg, Paulo Antonio Oldani Felix, Igor Age Kos

Pageof 1

Frequent Collaborators

2 joint publications

Moritz Bewarder

1 joint publications

Onur Cetin

1 joint publications

Eva C Schwarz

1 joint publications

Lorenz Thurner